Thibault de Chalus

Thibault de Chalus is currently serving as the Oncology Business Excellence Director at AstraZeneca since March 2023, overseeing various departments including Sales Force Effectiveness and Operational Excellence with a team of 21 FTEs. Prior to this role, Thibault worked at Amgen from 2016 to 2023, where responsibilities included leading Innovation, Digital & Omnichannel efforts, establishing the French Innovation Department, and managing market access strategies. Thibault also gained experience at UCB as a Market Access Manager, handling reimbursement and pricing dossier submissions, and conducted HEOR studies. Additional experience includes a position as a Business Development Analyst at Norgine and an internship in veterinary medicine. Thibault holds a Master's degree in Management from ESSEC Business School, a veterinary doctorate from École nationale vétérinaire d'Alfort, and is currently enrolled in the Market Access Academy Programme at The London School of Economics and Political Science.